Hi Guest Login
Home > Tests > Fecal Elastase > Zirakpur
₹6090 ₹4872
Report Time
Report by Tue/FriFREE
Home Sample Collection
Age Group
Parameters Included
1
Recomended for
Both
Fasting
No Fasting Required
Report Time
Report by Tue/Fri
Exclusive Offer
₹4872
₹6090
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The Fecal Elastase Test is a simple, non-invasive stool test that measures the level of elastase-1, an enzyme produced by the pancreas, to assess how well the pancreas is functioning. For residents of Zirakpur, this test is conveniently accessible through home sample collection services, making it easy to evaluate digestive and pancreatic health without a hospital visit. Reduced elastase levels can indicate exocrine pancreatic insufficiency (EPI), a condition in which the pancreas does not produce enough digestive enzymes, often linked to chronic pancreatitis, cystic fibrosis, diabetes, or other digestive disorders. The Fecal Elastase Test is essential for identifying these conditions early, enabling timely diagnosis, appropriate enzyme replacement therapy, and effective management of symptoms such as bloating, weight loss, and poor nutrient absorption.
The Fecal Elastase Test measures the amount of elastase, a digestive enzyme produced by the pancreas, in a stool sample. Elastase plays a key role in protein digestion, and its levels can indicate how well the pancreas is functioning. Because elastase remains stable as it passes through the digestive system, measuring it in stool provides a reliable assessment of pancreatic enzyme production. Low fecal elastase levels may suggest exocrine pancreatic insufficiency (EPI) or other pancreatic disorders, helping healthcare providers identify conditions that can affect digestion and nutrient absorption.
The fecal elastase test (also known as pancreatic elastase-1 or fecal elastase-1) is a non-invasive diagnostic test measuring the concentration of human pancreatic elastase in a stool sample. Pancreatic elastase is a proteolytic enzyme made by the acinar cells of the pancreas and released into the gastrointestinal tract to break down food, especially collagen and other proteins.
Elastase is stable during intestinal transit. Unlike other pancreatic enzymes that degrade in the gut, elastase remains intact. Its concentration in feces is about six times higher than in pancreatic fluid. This stability makes fecal elastase concentration an excellent marker of pancreatic exocrine function, specifically the pancreas's ability to produce and release enzymes needed for digestion.
This test provides critical information that helps doctors:
Overall, the fecal elastase test provides a simple, reliable, and non-invasive assessment of pancreatic exocrine function. By providing measurable data on the pancreas's digestive capacity, it helps doctors diagnose pancreatic insufficiency early, start enzyme replacement therapy, and monitor treatment response without invasive procedures.
Exocrine pancreatic insufficiency often presents with digestive symptoms that can be mistaken for other gastrointestinal disorders. The fecal elastase test is typically ordered when a person has persistent, unexplained symptoms suggestive of malabsorption or pancreatic dysfunction.
Loose, watery stools occurring frequently over weeks or months without an identifiable cause may indicate pancreatic insufficiency. Unlike infectious diarrhea, it often persists despite standard treatments and may be linked to other malabsorption features.
Steatorrhea is a hallmark of exocrine pancreatic insufficiency. Stools may appear greasy or oily, leaving a visible oil film on the toilet water. Bulky and pale—clay-colored or light yellow. Foul-smelling, particularly unpleasant odor. Difficult to flush—stools that float and stick to the toilet bowl.
This happens because fat is not properly digested or absorbed, so it passes through the intestines and is excreted in the stool.
Losing weight without trying, despite a normal or increased appetite, suggests malabsorption. When the pancreas does not produce enough enzymes, nutrients are not properly absorbed, leading to weight loss and malnutrition.
Many patients with pancreatic insufficiency experience upper abdominal pain may be dull, aching, or cramping; postprandial bloating, feeling excessively full after meals; and excessive flatulence due to fermentation of undigested food in the colon.
Despite adequate food intake, patients with pancreatic insufficiency may develop deficiencies in fat-soluble vitamins (A, D, E, K) and other nutrients, leading to: bone pain or fractures (vitamin D deficiency); easy bruising or bleeding (vitamin K deficiency); night blindness (vitamin A deficiency); and muscle weakness and neuropathy (vitamin E deficiency).
The fecal elastase test is particularly useful for patients with conditions known to cause exocrine pancreatic insufficiency:
|
Condition |
Association with EPI |
|
Chronic pancreatitis |
Progressive destruction of pancreatic tissue leads to enzyme deficiency |
|
Cystic fibrosis |
Thick mucus blocks pancreatic ducts, preventing enzyme release |
|
Pancreatic cancer |
Tumor may obstruct pancreatic ducts or destroy enzyme-producing tissue |
|
Type 1 diabetes mellitus |
Autoimmune damage may affect both endocrine and exocrine pancreas |
|
Type 2 diabetes (long-standing) |
Some patients develop exocrine dysfunction over time |
|
Acute pancreatitis (recurrent) |
Repeated episodes can lead to permanent damage |
|
Shwachman-Diamond syndrome |
Rare genetic disorder affecting pancreatic development |
|
Cholelithiasis (gallstones) |
May be associated with pancreatic dysfunction |
The fecal elastase test plays a critical role in the diagnosis, classification, and management of exocrine pancreatic insufficiency.
When a patient has symptoms of malabsorption—chronic diarrhea, steatorrhea, weight loss, or abdominal pain—the fecal elastase test helps determine if pancreatic dysfunction is the cause. A low elastase level confirms the pancreas is not producing enough digestive enzymes.
For patients with known pancreatic disease (chronic pancreatitis, cystic fibrosis), serial fecal elastase testing helps monitor the progression of exocrine dysfunction over time. This information guides decisions about enzyme replacement therapy.
When fecal elastase confirms pancreatic insufficiency, doctors can prescribe pancreatic enzyme replacement therapy (PERT). The test results help determine whether enzyme therapy is needed, the appropriate initial dose, and if dose adjustments are required based on symptom response.
Patients with severe pancreatic insufficiency (elastase <100 µg/g) are at high risk for malnutrition and fat-soluble vitamin deficiencies. Identifying these patients allows for timely nutritional intervention, including vitamin supplementation and dietary counseling.
While less common, some patients with pancreatic insufficiency may present with constipation rather than diarrhea. The test can be useful in evaluating chronic constipation when other causes have been excluded.
The fecal elastase test measures the concentration of human pancreatic elastase in a stool sample. Results are reported in micrograms of elastase per gram of stool (µg/g).
|
Result Range |
Interpretation |
Clinical Significance |
|
≥200 µg/g |
Normal pancreatic function |
Adequate enzyme production; pancreatic insufficiency is unlikely |
|
100–199 µg/g |
Moderate to mild exocrine pancreatic insufficiency |
Reduced enzyme production; may cause mild symptoms; clinical correlation needed |
|
<100 µg/g |
Severe exocrine pancreatic insufficiency |
Significant enzyme deficiency; high likelihood of malabsorption symptoms; pancreatic enzyme replacement therapy typically indicated |
Test results should always be interpreted alongside symptoms, medical history, and other investigations. Values outside the normal range do not always confirm disease, and normal results do not completely rule out underlying issues.
Lower elastase levels indicate greater pancreatic insufficiency. Severe deficiency (<100 µg/g) often requires enzyme replacement therapy, while moderate levels (100–199 µg/g) may present with mild or no symptoms.
In early-stage pancreatic conditions, enzyme levels may still appear normal. Therefore, a normal fecal elastase result does not completely exclude pancreatic disease.
This test is recommended for individuals with symptoms or conditions suggestive of exocrine pancreatic insufficiency.
Individuals experiencing persistent diarrhea, greasy or foul-smelling stools, or difficulty flushing stool should be evaluated for pancreatic insufficiency. These symptoms are often the first indication of EPI.
When a patient is losing weight despite normal or increased food intake, or shows signs of nutritional deficiencies (low vitamins A, D, E, or K), pancreatic insufficiency should be considered as a potential cause.
Chronic pancreatitis – Regular monitoring of pancreatic function is recommended Recurrent acute pancreatitis – Assess for progression to exocrine insufficiency Pancreatic cancer – Evaluate for associated EPI before and after treatment
Exocrine pancreatic insufficiency is present in approximately 85-90% of individuals with cystic fibrosis. The fecal elastase test helps assess the severity of insufficiency and guide enzyme replacement therapy.
Type 1 diabetes – Many patients develop some degree of exocrine dysfunction due to shared autoimmune mechanisms Long-standing type 2 diabetes – May also be associated with reduced pancreatic enzyme production
When other causes of malabsorption (celiac disease, Crohn's disease, bacterial overgrowth) have been ruled out, the fecal elastase test helps determine if pancreatic dysfunction is responsible.
Some bariatric procedures can affect pancreatic function. Preoperative and postoperative testing may be recommended in certain cases.
The following table provides a quick overview of the key details of the Fecal Elastase Test.
|
Parameter |
Details |
|
Test Name |
Fecal Elastase Test |
|
Also Known As |
Pancreatic Elastase-1, Fecal Elastase-1, Stool Elastase, ELASP |
|
Sample Type |
Stool (formed stool preferred; watery samples may give falsely low results) |
|
Gender |
Both |
|
Age Group |
All (including infants and children) |
|
Fasting Required |
No |
|
Report Time |
48–72 Hours |
|
Home Collection |
Available |
This may vary based on lab conditions please contact your doctor befoter referring this table
|
Result |
Interpretation |
|
≥200 µg/g |
Normal pancreatic function |
|
100–199 µg/g |
Moderate/mild pancreatic insufficiency |
|
<100 µg/g |
Severe pancreatic insufficiency |
Preparing for the fecal elastase test is straightforward, but following instructions carefully is essential for accurate results.
Several factors can influence the accuracy and interpretation of fecal elastase test results.
|
Factor |
Effect on Result |
Recommendation |
|
Watery or liquid stool |
Dilution causes falsely low elastase levels |
Collect from formed stool if possible; repeat testing may be needed |
|
Sample contamination with urine or water |
Invalidates the sample |
Collect carefully to avoid contamination |
|
Sample age |
Elastase is stable for several days, but delayed transport may affect results |
Return sample within 3 days of collection |
|
Very low sample volume |
Insufficient for testing |
Provide at least 200 mg of stool (approximately half a teaspoon) |
|
Blood in stool |
Sample may be rejected |
Avoid collecting samples with visible blood |
|
Mild pancreatic insufficiency |
May produce borderline results (100-200 µg/g) |
Clinical correlation needed; repeat testing after 3 months if indicated |
|
Early-stage pancreatic disease |
May not yet affect elastase levels |
Normal result does not completely rule out pancreatic disease |
Fecal elastase results are reported as a numerical value in micrograms of elastase per gram of stool (µg/g). Interpretation should always be done by a gastroenterologist or physician considering clinical symptoms and medical history.
|
Result |
Interpretation |
Clinical Implications |
Next Steps |
|
≥200 µg/g |
Normal pancreatic function |
Adequate enzyme production; pancreatic insufficiency unlikely |
Consider other causes of symptoms (celiac disease, IBS, bacterial overgrowth) |
|
100–199 µg/g |
Moderate to mild exocrine pancreatic insufficiency |
Reduced enzyme production; may cause mild symptoms |
Clinical correlation; consider trial of pancreatic enzymes if symptomatic; repeat testing in 3 months if clinical suspicion remains |
|
<100 µg/g |
Severe exocrine pancreatic insufficiency |
Significant enzyme deficiency; high likelihood of malabsorption symptoms |
Pancreatic enzyme replacement therapy (PERT) typically indicated; monitor fat-soluble vitamin levels; dietary counseling |
Choosing the right diagnostic provider is essential for accurate pancreatic function testing and reliable results.
Sample collection guidance is provided by trained professionals who ensure proper specimen collection, handling, and transport to maintain sample integrity.
All samples are processed in NABL-accredited laboratories using validated ELISA or chemiluminescence methods for high accuracy.
MAX@Home understands the unique requirements of fecal elastase testing, including the importance of collecting formed stool and proper transport conditions.
Schedule your test at a convenient time with doorstep delivery of collection kits and sample pickup, eliminating the need for hospital visits.
From booking to report delivery, MAX@Home provides complete support throughout the process, including guidance on proper sample collection.
Reports are typically delivered within 48–72 hours, enabling timely gastroenterology consultation.
Backed by Max Healthcare's clinical expertise, MAX@Home brings hospital-grade diagnostics to your home.
Early diagnosis of exocrine pancreatic insufficiency can prevent malnutrition, improve quality of life, and guide appropriate enzyme replacement therapy. Do not ignore chronic diarrhea, greasy stools, or unexplained weight loss.
Read More
You've selected items to compare.
View All